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ORIGINAL ARTICLE
Obesity is an epidemic problem in the industri-
alized world and is also a growing problem in
Taiwan.1 The metabolic syndrome (MS) is a clus-
tering of cardiovascular disease risk factors includ-
ing dyslipidemia, hypertension, hyperglycemia
and abdominal obesity.2–5 Individuals with MS
or obesity have increased incidence of diabetes
mellitus and coronary heart disease, and in-
creased mortality from cardiovascular diseases
(CVD).6–11 A widely used definition of this syn-
drome was originally released in the Third Report
of the National Cholesterol Education Program
Expert Panel on Detection, Evaluation and
Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III [ATP III]) in 2000.3
The waist circumference cutoff point in the ATP
III criteria was subsequently revised as suggested
by the 2000 World Health Organization (WHO)
kAsia Pacific Guidelines because the absolute ris
of diabetes and CVD is higher in Asians who are
less obese.12–15 Two other definitions of MS from
the Bureau of Health Promotion in Taiwan16 and 
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a consensus statement from the International
Diabetes Federation17 for Chinese were released in
2005. The recent Diabetes Prevention Program18
demonstrated the effectiveness of lifestyle modifi-
cation, changes in diet and physical activity in the
resolution of MS. These findings illustrate the 
importance of identifying affected individuals
and intervention to prevent disease progression.
Assessment of the available diagnostic criteria 
sets for MS allows accurate identification of high
risk clusters related outcomes, such as CVD or 
diabetes in different populations.
Data on the relationship between obesity and
MS, and comparative study of the three different
definitions of MS in Taiwanese adults are lack-
ing. This study estimated the prevalence of MS
and obesity in Taiwanese by age and sex, and 
examined the association between overweight,
obesity and each of the components of MS.
Results obtained using the modified ATP III,
International Diabetes Federation Chinese ver-
sion (MS-IDF(C)) and the MS criteria for
Taiwanese (MS-TW) were compared and differ-
ences in the characteristics of patients meeting
these different criteria sets for MS were assessed.
Methods
Subjects
In 2002, a total of 7566 subjects participated in 
a nationwide cross-sectional population-based sur-
vey, named the Taiwanese Survey on Prevalence of
Hyperglycemia, Hyperlipidemia and Hypertension
(TwSHHH). The sample of the TwSHHH was
based on the National Health Interview Survey
(NHIS) in 2001 that employed a multistaged, strati-
fied and clustering sampling scheme.19 The NHIS’
Sampled Household Registration List covered 359
administrative districts that were divided into
seven different strata according to geographic prox-
imity. Households were sampled within strata
using the probabilities proportional to size
method. The final sample size was 26,685 non-
institutionalized residents from 6592 households
in 1648 communities. Half of the NHIS’ Sampled
Household Registration List (824 communities
with 3296 households) in each stratum were
randomly selected for the TwSHHH. All subjects
gave written informed consent for participation.
Subjects were excluded if they lacked a blood speci-
men (n=973), were older than 80 years (n=100)
or younger than 20 years (n= g557). The remainin
5936 subjects were included in the analyses. No
significant differences in the prevalence of meta-
ybolic disorders were found between the stud  
subjects and excluded subjects.
Data collection
Data on sociodemographic characteristics includ-
ing sex, age, physical activity, menopausal status, di-
etary habits, family history of cardiovascular-related
diseases, physician-diagnosed diseases and medica-
tion history were collected by nurses who adminis-
gtered a questionnaire during a home visit. Durin
the visit, sitting blood pressure (BP) and anthropo-
metric measurements were made. Two BP readings
rwere taken 30 seconds apart in the right arm afte
the participant had sat and rested for 5–10 minutes.
A third BP measurement was made if the first two
BP readings differed by more than 10mmHg. The
average of the two closest readings was calculated
and used in the analysis. Waist circumference was
measured at the narrowest point with a tape meas-
ure placed parallel to the floor at the end of a re-
glaxed expiration with the participants standin
akimbo. NaF plasma was collected for fasting GLU
tanalysis, and serum was collected for measuremen
of lipids. Blood samples were transported at −10°C
in dry ice to the central laboratory, stored at −20°C
and analyzed within 2 weeks. Fasting total choles-
terol (Lieberman–Burchard method), triglyceride
(TG) (Bucolo method) and fasting plasma glucose
(FPG) (glucose oxidase method) were measured
by an automated system (Vitros 550/750, Ortho-
Clinical Diagnostics Inc., a Johnson and Johnson
Company, Rochester, NY, USA). Electrophoresis
was performed to measure high-density lipopro-
tein cholesterol (HDL-C) and low-density lipopro-
tein cholesterol (LDL-C). Body mass index (BMI)
ywas calculated as weight in kilograms divided b
the square of the height in meters. BMI cutoffs
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were adopted as suggested by the Department 
of Health in Taiwan including normal (18.5 ≤
BMI < 24), overweight (24 ≤ BMI < 27) and obese
(BMI ≥27) categories.
Diagnostic criteria for MS
The definition of abdominal obesity was modi-
fied according to the 2000 WHO Asia Pacific
Guidelines20 as a waist circumference > 90 cm in
men and > 80 cm in women. In this study, classi-
fication of MS according to the modified ATP III
criteria for Asians21 required meeting at least
three of the following component risk factors:
(1) waist circumference > 90 cm for men and
> 80 cm for women; (2) TG ≥ 150 mg/dL; (3)
HDL-C < 40 mg/dL for men and < 50 mg/dL for
women; (4) systolic BP ≥ 130 mmHg or diastolic
BP ≥ 85 mmHg or current use of antihypertensive
drugs; (5) FPG ≥ 110 mg/dL or current use of anti-
hyperglycemic drugs. The components and crite-
ria of the MS-TW17 in this study were similar to
the modified ATP III but in the component of
obesity included BMI ≥ 27 kg/m2, waist circum-
ference > 90 cm for men and > 80 cm for women.
In this study, the MS-IDF(C)18 criteria were
abdominal obesity (defined as waist circumfer-
ence > 90 cm for men and > 80 cm for women
and any two of the following four factors: (1)
TG ≥ 150 mg/dL; (2) HDL-C < 40 mg/dL for men
and < 50 mg/dL for women; (3) systolic BP ≥
130 mmHg or diastolic BP ≥ 85 mmHg, or treat-
ment of previously diagnosed hypertension; (4)
FPG ≥ 100 mg/dL or a previous diagnosis of type
2 diabetes. We did not include dyslipidemia
therapy in the criteria because of the inability 
to collect accurate information regarding this
parameter by personal interview.
Statistical analysis
Data were analyzed using SAS version 8.02 (SAS
Institute Inc., Cary, NC, USA). The criteria for
statistical significance were p < 0.05 and a 95%
confidence interval of odds ratios (OR) that 
excluded 1.
In 2001, the prevalence of MS was age-
standardized by the Taiwanese population using
a direct standardization method. The trend of preva-
lence of  obesity or MS in different age groups
was tested by Cochran–Armitage trend test.
Comparison of the prevalence of MS and its
components among different BMI categories was
performed by logistic regression analyses with
adjustment for age, serum LDL-C level, exercise
habit, alcohol drinking and smoking status.
rLogistic regression was also used to test fo
trends of ORs of BMI categories of MS and its
components. Study subjects with normal BMI
served as controls.
Results
Sample characteristics
rThe number of subjects with adequate data fo
inclusion in all of the statistical analyses was 5936
(men/women, 2815/3121). The mean age of these
subjects was 44.7 ± 15.0 years (range, 20–79.9
years) and mean BMI was 23.7 ± 3.7kg/m2 (24.3 ±
3.5 in men and 23.1 ± 3.8 in women). The charac-
teristics of the study sample are summarized in
Table 1. There was a high prevalence of individual
gcomponents of MS in this study sample, includin
abdominal obesity in 30.2%, high TG in 27.6%,
low HDL-C in 23.8%, high BP in 29.9%, impaired
FPG (FPG ≥ c110mg/dL) or taking antihyperglycemi
medication in 10.6%, and FPG > 100mg/dL or pre-
viously diagnosed type 2 diabetes in 18.4% (Table
1). High BP was the most commonly identified
metabolic component in men, while abdominal
obesity was the most common in women. Men had
a higher prevalence of high TG (p < 0.0001), high
BP (p < 0.0001) and high FPG (p < 0.05) than
women. The frequencies of low HDL-C concentra-
tion (p < 0.0001) were higher in women than men.
rThe majority of participants (61.4%) had one o
more metabolic risk factors.
Prevalence of overweight, obesity and
abdominal obesity
Figure 1 shows the sex- and age-specific preva-
lence of abdominal obesity, overweight and obe-
f sity. Men had significantly higher prevalence o
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overweight (BMI 24–26.9 kg/m2) and obesity
(BMI ≥27 kg/m2) than women (overweight, 30.5%
vs. 21.3%, p < 0.0001; obesity, 19.2% vs. 13.4%, p <
0.0001). However, the overall prevalence of ab-
dominal obesity in men and in women was simi-
lar. Based on the 2000 WHO Asia Pacific
Guidelines, the age-standardized prevalence of 
abdominal obesity was 28.3% in men and 28.7%
in women, and increased with age in men and
women (trend test, p < 0.0001). The prevalence of
abdominal obesity in women increased rapidly
after the menopausal period and was higher in
men, but showed a crossover beyond the age group
of 50–59 years, becoming higher in women. The
prevalence of abdominal obesity differed from
that of the obesity categories of BMI. In young and
middle-aged adults, the frequency of overweight
and obesity (BMI ≥24 kg/m2) was greater than that
of abdominal obesity, but this relationship was 
opposite beyond the age group of 50–59 years 
in women. The cutoff values of waist circumfer-
ence corresponding to the highest sensitivity and
specificity in BMI ≥27 kg/m2 were 89.6 cm in men
fand 80.2 cm in women, respectively. These cutof
values of waist circumference were similar to the
criteria of the 2000 WHO Asia Pacific Guidelines
as a waist circumference > 90 cm in men and
> 80 cm in women.
Prevalence of MS
The age-standardized prevalence of MS using the
three different criteria sets was as follows: modi-
fied ATP III criteria, 15.7% (18.3% in men,
13.6% in women); MS-TW, 16.4% (19.5% in
men, 13.8% in women); MS-IDF(C), 14.3%
(16.1% in men, 13.3% in women). The preva-
lence of MS increased with age (trend test, p <
0.0001), reaching peak levels in the 7th fdecade o
flife for both men and women. The prevalence o
MS in the overall group increased from 5.2% in
the 20–29-year-old group to 36.5% in the 70–79-
year-old group. Figure 2 shows the sex- and age-
specific prevalence of MS as well as the overall
frequencies using the three different definitions
of the modified ATP III, MS-TW and MS-IDF(C)
criteria. The prevalence of MS in women increased
Table 1. Characteristics of the study sample
Total subjects (n = 5936) Men (n = 2815) Women (n = 3121) p
Age (yr) 44.7 ± 15.0 45.0 ± 15.4 44.4 ± 14.7 0.1013
BMI (kg/m2) 23.7 ± 3.7 24.3 ± 3.5 23.1 ± 3.8 < 0.0001
Overweight (%), 24 ≤ BMI < 27 25.8 30.5 21.3 < 0.0001
Obesity (%), BMI ≥ 27 16.4 19.2 13.4
Waist circumference (cm) 80.5 ± 10.9 84.4 ± 10.2 76.3 ± 10.0 < 0.0001
W/H ratio 0.83 ± 0.08 0.87 ± 0.07 0.79 ± 0.07 < 0.0001
Systolic BP (mmHg) 116 ± 18.2 119.3 ± 16.6 112.9 ± 18.9 < 0.0001
Diastolic BP (mmHg) 75.5 ± 11.3 78.4 ± 10.9 72.8 ± 10.9 < 0.0001
FPG 95.3 ± 30.0 96.1 ± 30.5 94.6 ± 29.4 0.0593
TG 130.7 ± 87.0 148.3 ± 97.5 115.1 ± 72.9 < 0.0001
HDL-cholesterol (mg/dL) 55.4 ± 15.3 51.3 ± 15.1 59.2 ± 14.4 < 0.0001
Abdominal obesity* (%) 30.2 29.5 30.8 0.2606
High TG level (%) 27.6 35.2 20.7 < 0.0001
Low HDL-cholesterol level (%) 23.8 22.5 25.1 0.019
High BP (%) or taking medication 29.9 36.6 23.9 < 0.0001
High FPG ≥ 110 mg/dL (%) or 10.6 11.5 9.8 0.0362
taking medication
High FPG ≥ 100 mg/dL (%) or 18.7 20.0 17.5 0.0143
taking medication
*Asian criteria: waist circumference > 90 cm in men, > 80 cm in women. BMI = body mass index; W/H ratio = waist/hip circumference ratio; BP = blood
pressure; FPG = fasting plasma glucose; TG = triglyceride; HDL = high-density lipoprotein (< 40 mg/dL in men, < 50 mg/dL in women).
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rapidly after the menopausal period becoming
higher than in men, resulting in a crossover point
at the age group of 60–69 years by gender.
The relative frequencies of the individual
components of MS by sex and BMI are shown in
Table 2. Higher categories of BMI were signifi-
cantly associated with a greater proportion of MS
and with each component, including abdominal
obesity, high TG, low HDL-C, high BP and high
FPG in both men and women.
MS was found primarily in those subjects
fwho were overweight or obese. Only 6.5% o
subjects with a healthy body weight (18.5 ≤ BMI
< 24 kg/m2) had MS according to MS-TW criteria,
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in contrast to rates of 50.2% among subjects
with BMI > 27. A substantial increase in the
prevalence odds of MS was observed with in-
creasing levels of BMI. ORs of MS and its compo-
nents increased progressively in association with
BMI ≥ 24 kg/m2. If the risk of MS with BMI of
18.5–24 kg/m2 was defined as 1.0, then the ORs
were 2.07–3.79 with BMI of 24–26.9 kg/m2, and
6.24–17.3 with BMI > 27. ORs of overweight or
obesity for MS in women were higher than in
men, regardless of the criteria used.
Comparison of the three definitions of MS
tThe characteristics of subjects with discordan
classification among the three different criteria
sets for MS are shown in Table 3. The modified
yATP III and MS-TW criteria for MS were met b
173 subjects who did not meet the MS-IDF(C) cri-
teria. These subjects did not meet the abdominal
obesity requirement of the MS-IDF(C), but had
other risk components, a history of hypertension
or type 2 diabetes, which led to the MS classifi-
cation by the other criteria sets. In contrast, the
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MS-IDF(C) = metabolic syndrome definition by the International Diabetes Federation criteria for Chinese.
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MS-IDF(C) criteria were met by 81 subjects with
abdominal obesity and with FPG in the range of
100–109 mg/dL who did not meet the require-
ments of the modified ATP III and MS-TW criteria.
The MS-TW criteria were met by 35 more sub-
jects than the modified ATP III, including 11 with
a history of hypertension, one with a history of
diabetes, one with a history of stroke and four
with a history of heart disease.
Discussion
This cross-sectional population study found that
overweight, obesity and MS were common among
Taiwanese adults. BMI ≥ 27 kg/m2 was found in
19.2% of men and 13.4% of women. The three
criteria sets for MS were met by the following 
ypercentages of subjects: modified ATP III criteria b
18.3% of men and 13.6% of women; MS-IDF(C)
Wby 16.1% of men and 13.3% of women; MS-T
by 19.5% of men and 13.8% of women. The
prevalence of MS increased directly with the degree
of obesity. Moreover, each component of this syn-
drome significantly decreased with increasing BMI
categories. Comparison of the findings using the
three criteria sets for MS revealed that the MS-
IDF(C) criteria underestimated the combination
rof all risk components of the modified ATP III o
MS-TW criteria except for abdominal obesity.
Prevalence of obesity
An increase in the prevalence of overweight and
obesity has been noted in most Asian countries
during the last two decades.13,14 yThere is currentl
an epidemic of obesity in Taiwan. The BMI ranges
Table 2. Prevalence and age-adjusted odds ratios for metabolic syndrome and its components by categories of body mass
index (kg/m2)
BMI categories
18.5–23.9 24.0–26.9 ≥ 27
% OR (95% CI) % OR (95% CI) % OR (95%CI)
p for trend
Men
Abdominal obesity* (%) 6.5 1.0 34.8 5.33 (4.18–6.78) 79.2 51.04 (37.39–69.66) < 0.0001
High TG (%) 23.2 1.0 43.3 2.18 (1.79–2.64) 56.7 3.41 (2.72–4.28) < 0.0001
Low HDL-C (%) 15.0 1.0 27.9 2.25 (1.82–2.79) 34.6 3.25 (2.55–4.15) < 0.0001
High blood pressure (%) 27.4 1.0 41.4 1.59 (1.31–1.94) 48.7 2.77 (2.20–3.50) < 0.0001
High FPG ≥ 110 mg/dL (%) 6.5 1.0 14.2 1.92 (1.45–2.60) 16.9 2.80 (2.03–3.87) < 0.0001
High FPG ≥ 100 mg/dL (%) 13.0 1.0 23.3 1.72 (1.37–2.17) 29.7 2.81 (2.17–3.65) < 0.0001
Modified ATP III (%) 6.5 1.0 23.7 3.09 (2.40–3.99) 44.1 9.22 (6.98–12.16) < 0.0001
MS-TW (%) 6.5 1.0 23.7 3.06 (2.38–3.95) 50.5 11.97 (9.08–15.77) < 0.0001
MS-IDF(C) (%) 3.3 1.0 18.5 3.79 (2.81–5.11) 45.5 17.3 (12.62–23.72) < 0.0001
Women
Abdominal obesity* (%) 8.9 1.0 48.6 5.08 (4.05–6.36) 88.9 61.44 (41.89–90.10) < 0.0001
High TG (%) 12.2 1.0 28.0 1.74 (1.38–2.19) 39.5 2.87 (2.21–3.73) < 0.0001
Low HDL-C (%) 21.6 1.0 27.3 1.26 (1.02–1.55) 32.1 1.60 (1.25–2.04) < 0.0001
High blood pressure (%) 14.1 1.0 31.0 1.53 (1.21–1.94) 42.4 2.80 (2.13–3.68) < 0.0001
High FPG ≥ 110 mg/dL (%) 4.7 1.0 11.3 1.26 (0.92–1.74) 21.1 2.68 (1.94–3.69) < 0.0001
High FPG ≥ 100 mg/dL (%) 10.0 1.0 22.5 1.49 (1.16–1.90) 33.6 2.63 (2.01–3.45) < 0.0001
Modified ATP III (%) 4.5 1.0 20.2 2.08 (1.58–2.71) 40.2 6.24 (4.68–8.31) < 0.0001
MS-TW (%) 4.5 1.0 20.2 2.07 (1.58–2.72) 41.0 6.48 (4.87–8.63) < 0.0001
MS-IDF(C) (%) 2.8 1.0 21.6 2.95 (2.24–3.89) 48.4 10.00 (7.45–13.45) < 0.0001
*Asian criteria: waist circumference > 90 cm in men, > 80 cm in women. BMI = body mass index; OR = odds ratio; CI = confidence interval; TG = triglyceride;
HDL-C = high-density lipoprotein cholesterol (< 40 mg/dL in men, < 50 mg/dL in women); FPG = fasting plasma glucose; ATP III = Adult Treatment Panel III;
MS-TW = metabolic syndrome by Taiwan criteria; MS-IDF(C) = metabolic syndrome by International Diabetes Federation criteria for Chinese.
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for overweight and obesity recommended by the
Department of Health in Taiwan are 24–26.9 and
≥27 kg/m2, respectively, and are lower than the
ranges of 25–29.9 and ≥30.0 kg/m2 in the WHO
classification. The National Nutrition and Health
Survey in Taiwan conducted from 1993 to 1996
reported that the prevalence of obesity was 10.5%
for men and 13.2% for women.1 The results of 
this cross-sectional survey conducted in 2002 show
that the prevalence in men has increased drama-
tically to 19.2% while remaining comparatively
unchanged in women at 13.4%. Whereas the peak
prevalence of obesity in men was in the age group
of 40–49 and then declined slightly, women
showed a continuously increasing prevalence of
obesity with age. In general, the prevalence of ab-
dominal obesity increased until the age of 70–79
years in both men and women, and this increase
was most obvious in postmenopausal women.
In comparison with Caucasians, Asians have
a much lower reported prevalence of obesity, but
the clustering of cardiovascular risk factors is
thought to occur in this relatively lean population
as well.22–26 Reported clustering metabolic condi-
tions include BMI > 23 kg/m2 in China,12,15 BMI
25–29.9 kg/m2 in Japan,25 BMI 21.9–23.8 kg/m2 in
Korea,26 and BMI ≥23.6 in men and ≥22.1 kg/m2
in women in Taiwan.24
Prevalence of MS
A wide variation in the prevalence of MS has
kbeen reported in different studies. The Brunec
Study in Italy found that 34.1% of subjects met the
WHO criteria for MS, while only 17.8% met the
ATP III criteria.27 The Third National Health and
Nutrition Examination Survey (NHANES III),
twhich included 8608 participants, found tha
the prevalence of MS was 23.9% using the ATP
III definition and 25.1% using the WHO defini-
tion, resulting in an 86.2% agreement rate.28 The
discrepancies in the prevalence of MS in various
studies are mainly attributable to differences in
the definitions of this syndrome and also in its
components, as well as to differences in the charac-
teristics of the populations studied.29–32 yA stud
in Shanghai found that the low prevalence of MS
of 10.2% using the WHO diagnostic criteria was
attributable to the low prevalence of obesity.12
The prevalence of MS might increase if the Asian
criteria for abdominal obesity were adopted. Stu-
gdies of MS prevalence in other countries usin
the modified ATP III criteria found rates of 19.2%
Table 3. Characteristics of subjects with discordant metabolic syndrome (MS) classification by the three criteria sets
Discordant MS classification (n = 289)
Modified ATP III (+) (+) (−) (+) (−) (−)
MS-TW (−) (−) (+) (+) (−) (+)
MS-IDF(C) (−) (+) (+) (−) (+) (−)
p
n 0 0 0 173 81 35
Female (%) 30.6 54.3 8.6 < 0.001
Age ≥ 50 yr (%) 55.5 62.9 14.3 < 0.001
Obesity, BMI ≥ 27 kg/m2 (%) 6.7 47.2 100.0 < 0.001
History of DM (%) 34.1 0.0 2.9 < 0.001
History of HTN (%) 68.2 50.6 31.4 < 0.001
Increased WC (%) 0.0 100.0 0.0 < 0.001
Increased TG (%) 95.9 27.2 91.4 < 0.001
Low HDL-C (%) 82.7 11.1 51.4 < 0.001
High blood pressure (%) 89.0 61.7 45.7 < 0.001
FPG ≥ 110 mg/dL (%) 45.7 0.0 11.4 < 0.001
FPG ≥ 100 mg/dL (%) 54.3 100.0 22.9 < 0.001
ATP III=Adult Treatment Panel III; MS-TW=metabolic syndrome by Taiwan criteria; MS-IDF(C)=metabolic syndrome by International Diabetes Federation cri-
teria for Chinese; BMI=body mass index; DM=diabetes mellitus; HTN=hypertension; Increased WC=waist circumference > 90cm in men and > 80cm in
women; TG= triglyceride; Low HDL-C= low high-density lipoprotein cholesterol (< 40 mg/dL in men and < 50mg/dL in women); FPG= fasting plasma glucose.
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in men and 16.4% in women in Singapore,33 and
20.8% in men and 26.9% in women in Korea.34 In
this nationwide cross-sectional study from Taiwan,
the age-standardized prevalence of MS was 15.7%
by the modified ATP III criteria, 14.3% by the MS-
IDF(C) criteria, and 16.4% by the MS-TW criteria.
These prevalences are all slightly lower than those
reported from other Asian countries.15,26,33,34 A
new diagnostic criteria for MS recently released by
the American Heart Association (AHA) and the
National Heart, Lung and Blood Institute35 is simi-
lar to the ATP III criteria, but criteria of high FPG is
≥ 100 mg/dL. In this study, analyzing with a ver-
sion of the AHA definition modified using Asian
criteria for waist circumference resulted in a preva-
lence of MS in Taiwan of 20.4% in men and 15.3%
in women aged 20–79 years.
Regardless of which of the three criteria sets
for MS was used, MS prevalence increased with
age and reached its peak in the 7th decade of life
for men and for women. This finding is in agree-
ment with the results of the NHANES III survey
in the United States and a study of nondiabetic
European men and women by the DECODE
Study Group.36 The prevalence of MS in women
increased rapidly after the menopausal period
and became higher than in men, with a crossover
point in the 50–59 years age group and with a
more obviously increasing slope in women in
the age range of 50–69 than in men. The increase
in CVD risk after menopause37 may be related to
the substantial metabolic changes that occur as
women transition from premenopause to post-
menopause. In many women, the features of MS
(abdominal adiposity, insulin resistance and dys-
lipidemia) emerge in conjunction with estrogen
deficiency.
Relationship between obesity and MS
This study found that the degree of excess weight
as measured by BMI was a strong predictor of
MS, with strong associations observed between
BMI and the individual components of MS. The
risks of MS and its components significantly in-
creased with BMI categories in men and women,
and were markedly increased in adults with
BMI ≥ 24 kg/m2. A strong association between
obesity and CVD risk factors was also found in
the Elderly Nutrition and Health Survey in
Taiwan conducted from 1999 to 2000.38
Comparison of MS prevalence using 
different criteria
Comparison of the different criteria sets for MS
fin this study revealed that, due to the absence o
gabdominal obesity, 173 subjects with clusterin
of CVD risk factors including type 2 diabetes
t(34.1%) and hypertension (68.2%) did not mee
the MS-IDF(C) criteria. Thus, use of these criteria
in Taiwan might lead to underestimation of the
risk of CVD. The prevalence of MS was the high-
est with the MS-TW criteria, which included BMI
≥ 27 kg/m2 rand waist circumference criteria fo
obesity, thereby identifying more subjects with
clustering of CVD risk factors than the modified
ATP III or MS-IDF(C) criteria.
In conclusion, this study of a representative
cross-sectional sample of adult Taiwanese showed
that overweight, obesity and MS are common
and that these conditions are strongly associated.
These findings underscore the urgent need to
develop comprehensive efforts directed at con-
trolling the obesity epidemic in Taiwan.
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